Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2025-12-26 @ 3:33 AM
NCT ID:
NCT02038218
Pre Assignment Details:
Patients with cancer involving the CNS were treated with intravenous DM-CHOC-PEN. The drug is metabolized by the liver. Abnormal neurological and hepatic values excluded the patients from treatments. If the patients were on steroids, this also excluded treatments. Steroids initiate the break down of DM-CHOC-PEN.
Recruitment Details:
Study completed - Tulane Medical Center (2017-19), Detroit Research Center (Lansing, Detroit and Owasso) 2017-19, Mt Sinai Medical Center, NYNY, 2014-18 and Ochsner Medical Centers (New Orleans, 2017-19.
Study:
NCT02038218
Study Brief:
Results Section:
NCT02038218